Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) Conference

related documents

• Discovery of HBW-3-10: A potent, orally active, reversible Bruton's tyrosine kinase (BTK) inhibitor with antitumor activity in mice.  Conferences
• Discovery of HBW-3-20, the first potent reversible inhibitor of Bruton's tyrosine kinase (BTK) with high brain exposure.  Conferences
• Does early palliative care reduce end-of-life hospital costs? A propensity-score matched, population-based, cohort study.  Conferences
• EORTC 1709/CCTG CE.8: A phase III trial of marizomib in combination with temozolomide-based radiochemotherapy versus temozolomide-based radiochemotherapy alone in patients with newly diagnosed glioblastoma.  Conferences
• Feasibility of a child life specialist program for oncology patients with minor children at home: Demand and implementation.  Conferences
• Feasibility of a child life specialist program for oncology patients with minor children at home: Qualitative analysis.  Conferences
• Fostering interspeciality learning in cancer survivorship care: Learning suite results.  Conferences
• Health-related quality of life in the treatment and survivorship phases of breast cancer.  Conferences
• ICES (International Carboplatin Emesis Survey) for the evaluation of the emetogenicity of continuous cycles of carboplatin-based chemotherapy with focus on nausea: A MASCC emesis study group, prospective, observational, real-world multi-centric study.  Conferences
• Impact of patient, tumour and treatment factors on psychosocial outcomes in invasive breast cancer.  Conferences
• Myocardial injury after gynecologic oncology surgery in septuagenarians and octogenarians: Is there a role for routine postoperative cardiac biomarker monitoring?  Conferences
• PSMA-PET/CT Registry for Recurrent Prostate Cancer (PREP): Initial findings from a single center.  Conferences
• Recurrent disease in patients with stage III melanoma in the era of adjuvant immune and targeted therapy.  Conferences
• Role of adjuvant therapy in esophageal cancer patients after neoadjuvant therapy and curative esophagectomy: A systematic review and meta-analysis.  Conferences
• Should we routinely screen for frailty prior to gynecologic oncology surgery? Frailty as a potential predictor of adverse postoperative outcomes in elderly patients.  Conferences
• Technology interventions to support adherence to oral oncolytic agents: A systematic review and meta-analysis.  Conferences
• The PROVIEW+ tool: Developing and validating a tool to predict risk of poor performance status and severe symptoms in cancer patients over time.  Conferences
• Treatment dependent improvements in survival of stage 2/3 rectal cancer patients treated with trimodality therapy between 2006-2016, an NCDB analysis.  Conferences